Ategra Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
CCM
Ategra Capital Management's NVS Position: Q2 2024 in Review
Ategra Capital Management sold out of Novartis (NVS) in Q2 2024, closing a stake of 3,933 shares — an estimated $380K sold.
Ategra Capital Management first reported a position in NVS in Q1 2019 and held it in 21 quarters. The position peaked at $476K in Q1 2019. 1,306 funds tracked by Wall St. Rank hold NVS as of Q2 2024.
- Ategra Capital Management reported no remaining Novartis position as of Q2 2024 after selling out during the quarter.
- Ategra Capital Management sold 3,933 Novartis shares in Q2 2024, an estimated $380K.
- Ategra Capital Management first reported a position in Novartis in Q1 2019 and held it in 21 quarters.
- Ategra Capital Management's Novartis position peaked at $476K in Q1 2019.
- 1,306 funds tracked by Wall St. Rank held Novartis as of Q2 2024.
Based on Ategra Capital Management's 13F filing for Q2 2024, filed 14 Feb 2025.